The Atlanta Braves are navigating a challenging situation with two of their promising right-handers, Spencer Schwellenbach and Hurston Waldrep, both undergoing surgery to remove loose bodies from their elbows. Manager Walt Weiss confirmed these procedures, noting that while no formal return timeline has been established, Schwellenbach is already on the 60-day injured list. Waldrep is expected to join him there soon.
Schwellenbach, who hinted at the need for surgery last week, remains out indefinitely. His absence is a significant blow, considering his impressive 3.23 ERA and strong strikeout-to-walk ratio since debuting in 2024. Waldrep, cleared of structural damage but needing surgery, was a strong contender for the fifth starter role after a solid rookie season with a 2.88 ERA.
With these setbacks, the Braves' rotation now leans on Chris Sale, Spencer Strider, Reynaldo Lopez, and Grant Holmes. While talented, this group carries its own set of concerns.
Sale, despite his past accolades, has battled injuries and hasn't had a fully healthy season since 2017. Strider is working back from UCL surgery, Lopez is returning from shoulder surgery, and Holmes is recovering from a UCL tear without surgery.
Despite these challenges, the Braves seem content with their current roster, downplaying the need for external additions. Reports suggest that previous interest in pitchers like Chris Bassitt and Lucas Giolito may have been overstated, possibly due to budget constraints.
As the Braves navigate these uncertainties, their ability to manage these injuries and maintain rotation stability will be crucial in their pursuit of success this season.